Literature DB >> 28656747

Metastatic endophthalmitis and thyroid abscess complicating Klebsiella pneumoniae liver abscess.

Seon-Jae Kim1, Seong Taek Chu1, Keun Sook Lee1, Seung Woo Nam1, Jong Kyoung Choi1, Joo Won Chung1, Hyeok Choon Kwon1.   

Abstract

The thyroid is resistant to infection due to its anatomical and physiological characteristics. We present a rare case of invasive liver abscess with metastatic thyroid abscess and endogenous endophthalmitis in a previously healthy 55-year-old female patient without diabetes or other medical illness. This report raises an important question of the virulence of Klebsiella pneumoniae as an increasingly common causative agent of liver abscess.

Entities:  

Keywords:  Endophthalmitis; Klebsiella pneumoniae; Liver abscess; Thyroid abscess

Mesh:

Substances:

Year:  2017        PMID: 28656747      PMCID: PMC5875196          DOI: 10.3350/cmh.2016.0066

Source DB:  PubMed          Journal:  Clin Mol Hepatol        ISSN: 2287-2728


INTRODUCTION

The prevalence of Klebsiella pneumoniae (K. pneumoniae) infection has been increasing since the late 1980s when anecdotal reports were published [1-3]. Now K. pneumoniae is the predominant pathogen in more than half of all liver abscesses [4]. Fang et al. [5] define invasive liver abscess syndrome as K. pneumoniae abscess with extrahepatic complications, resulting in severe complications and poor outcomes [2,6]. Extrahepatic complications resulting from bacteremic dissemination are reported frequently, including endophthalmitis, meningitis and necrotizing fasciitis [7,8]. We present a rare case of invasive liver abscess syndrome due to K.pneumoniae with metastatic endophthalmitis and thyroid abscess. The patient was a healthy 55-year-old female without any prior illness or predisposing hepatobilliary disease. Although the thyroid is resistant to infection, she presented with two distant metastatic infections. This report raises the importance of consideration of metastatic infection during treatment of liver abscess.

CASE REPORT

A 55-year-old female presented with left flank pain for one day. She was healthy and denied any illness. She was not being prescribed any medicine and rarely consumed alcohol. She denied travel history and taking any herbal medicine. Her vital signs were unremarkable. Laboratory tests revealed the following results: aspartate aminotransferase (AST) level, 66 U/L (normal range, 0-40 U/L); alanine aminotransferase (ALT) level, 74 U/L (normal range, 0-45 U/L); alkaline phosphatase (ALP) level, 186 U/L (normal range, 30-130 U/L); total bilirubin level, 1.4 U/L (normal range, 0.2-1.2 U/L); WBC level 14,600/mm3 and c-reactive protein (CRP) level 275 U/L (normal range, 0-3.0 U/L). Serologic tests for hepatitis B and C viruses and HIV antigen test were negative. Thyroid function test was normal. Abdominal CT scans demonstrated a 14.0x6.5cm sized lobulated, hypoechoic lesion in segment 2 and showed resolution after percutaneous transhepatic drainage (Fig. 1). On the second day after admission, the patient complained of visual disturbance and ophthalmic pain. She was diagnosed with metastatic endophthalmitis, and received intravitreal vancomycin and ceftazidime injection. On hospitalization day (HOD) 3 and HOD 8, she was treated with vitrectomy and lensectomy. On HOD 9, she complained of painful swelling with erythema on the left anterior aspect of her neck. CT scan of the neck showed a 3.5×2.5 cm sized heterogenous low density structure filled with fluid and wall enhancement by contrast (Fig. 2). Thyroid ultra-sound (US) revealed 3.5x2.5cm sized well-defined huge abscess which was resolved after drainage (Fig. 3). Ultra-sound (US) guided aspiration was performed for diagnosis and drainage was done twice on HOD 10 and HOD 13. She started antibiotic treatment with cefotaxime, metronidazole and amikacin at admission. K. pneumoniae was cultured from patient’s blood, liver aspirate and thyroid aspirate. The antibiotics was changed to cefotaxime only after isolating K. pneumoniae as the causative pathogen on culture. She was discharged on HOD 37 after a CT demonstrating resolution of liver and thyroid abscess and improving fever and CRP. However, she lost her right visual acuity on discharge.
Figure 1.

Computed tomographic (CT) scan. (A) Abdominal CT scans demonstrated a 14×6.5 cm sized Hypoechoic lesion in segment 2. (B) CT scans showed resolution after percutaneous transhepatic drainage.

Figure 2.

CT scan of the neck showed a 3.5×2.5 cm sized structure of low density, with heterogenous contents, including fluid, with dense wall and light contrast enhancement (arrow), (A) coronal, (B) axial.

Figure 3.

Thyroid Ultra-sound (US). (A) Ultra-sound (US) demonstrated a 35×25 mm sized well-defined huge abscess. (B) Ultra-sound (US) showed resolution after drainage.

DISCUSSSION

Klebsiella pneumoniae is a gram-negative, non-motile, lactose fermenting, rod-shape organism. This organism can be found in the mouth, skin, and intestinal tract, where it initially does not cause disease. But, it can progress into severe bacterial infections leading to pneumonia, urinary tract infections or meningitis. Haematogenous seeding has been considered as a possible route of septic metastases from pyogenic liver abscess [9]. In the past decades, prevalence of invasive liver abscess syndrome, KPLA with extrahepatic complications has increased in Asia. Taiwan has the highest prevalence, followed by South Korea [5,8]. The invasive nature of some K. pneumoniae strains includes a hypermucoviscous phenotype associated with serotypes K1 and K2 and the regulator of mucoid phenotype A gene. Almost all patients with severe infection with bacteremia, liver abscess, and extrahepatic infections are infected exclusively with K. pneumoniae serotypes K1 and K2, but not all infections with K1 or K2 serotypes result in liver abscess with extrahepatic infection [5]. Extrahepatic metastases sites include the skin, eyes, kidney, lungs, bones, prostate, muscle, and cerebrospinal fluid. Lungs, CNS, and eyes are the most common metastatic sites. Gram-negative organisms (e.g., E. coli) were other pathogens of liver abscess inducing extrahepatic complication but rare [5,9]. The metastatic complications in patients with K. pneumoniae liver abscess comprising endophthalmitis, central nervous system (CNS) infections and necrotizing fasciitis are usually severe and associated with poor outcomes [7,10,11]. As the prevalence of liver abscess has increased, the extrahepatic complications including endogenous endophthalmitis have increased in South Korea [12]. The prognosis for patients with endophthalmitis caused by K. pneumoniae is very poor; more than 85% of patients had a severe visual deficit [5,7,10,11]. Usually, thyroid abscess is related to a predisposing congenital variant, most commonly a pyriform sinus fistula or complication of a biopsy [13]. Metastatic thyroid abscess is a rare complication because the thyroid gland is resistant to infection due to its encapsulation, iodine concentration, rich lymphatic drainage and dual blood supply [14]. Reviews of thyroid abscess document a predisposing congenital variant and immunocompromised status with atypical pathogens [15-17]. While thyroid abscesses are uncommon, they are associated with significant risk of rapid progression and potential compromise of the airway, so prompt recognition and treatment are essential for improved patient outcomes. Both host and virulence factors such as diabetes mellitus and K. pneumoniae contribute to the pathogenesis of invasive liver abscess syndrome [18], but whether diabetes is an independent risk factor is uncertain. This patient was 55-year-old healthy woman without any history of diabetes or immunodeficiency. In this report, we describe the first case of K. peumoniae invasive liver abscess syndrome with thyroid abscess. The patient was a healthy middle-aged woman with no history of diabetes or immunocompromised status. However, she presented with extrahepatic complications at two different sites, endogenous endophthalmitis and thyroid abscess. In spite of prompt proper antibiotics and vitrectomy, she lost her right vision. Yoon reported that 9.9% of patients with a liver abscess caused by K. pneumoniae had an extrahepatic metastatic infection [4]. Both host and virulence factors contribute, but with this report we advocate that even when the patient has no predisposing risks, the patient can develop severe extrahepatic complications, and we should rapidly detect and urgently treat to avoid devastating complications. Clinical appraisal and action should include detecting bacteria-associated virulent factors, quick capsular serotyping, emergent radiologic evaluation, early adequate drainage and appropriate treatment with antibiotics.
  18 in total

1.  Necrotizing fasciitis associated with Klebsiella pneumoniae liver abscess.

Authors:  B S Hu; Y J Lau; Z Y Shi; Y H Lin
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

2.  Risk factors for developing metastatic infection from pyogenic liver abscesses.

Authors:  Shiuan-Chih Chen; Yuan-Ti Lee; Kuang-Chi Lai; Ken-Sheng Cheng; Long-Bin Jeng; Wei-Ya Wu; Chun-Chien Chen; Meng-Chih Lee
Journal:  Swiss Med Wkly       Date:  2006-02-18       Impact factor: 2.193

3.  Computed tomographic differences of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-Klebsiella pneumoniae.

Authors:  Sung-Bum Kim; Bo-Kyung Je; Kee Yeol Lee; Seung Hwa Lee; Hwan-Hoon Chung; Sang Hoon Cha
Journal:  J Comput Assist Tomogr       Date:  2007 Jan-Feb       Impact factor: 1.826

4.  Severity of disease as main predictor for mortality in patients with pyogenic liver abscess.

Authors:  Shiuan-Chih Chen; Chi-Chou Huang; Shih-Jei Tsai; Chi-Hua Yen; Ding-Bang Lin; Po-Hui Wang; Chun-Chieh Chen; Meng-Chih Lee
Journal:  Am J Surg       Date:  2009-03-06       Impact factor: 2.565

5.  A clinical study of Klebsiella liver abscess.

Authors:  F Y Chang; M Y Chou; R L Fan; M F Shaio
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1988-03

6.  Disseminated nocardiosis with thyroid involvement: a case report.

Authors:  Bo-An Su; Wen-Chien Ko; Yin-Ching Chuang; Hung-Jen Tang
Journal:  J Microbiol Immunol Infect       Date:  2011-01-18       Impact factor: 4.399

Review 7.  Infectious diseases of the thyroid gland.

Authors:  S A Berger; J Zonszein; P Villamena; N Mittman
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

8.  Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess.

Authors:  Susan Shin-Jung Lee; Yao-Shen Chen; Hung-Chin Tsai; Shue-Ren Wann; Hsi-Hsun Lin; Chun-Kai Huang; Yung-Ching Liu
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

9.  Liver abscess due to Klebsiella pneumoniae: risk factors for metastatic infection.

Authors:  Jai Hoon Yoon; Youn Jeong Kim; Yoon Hee Jun; Sang Il Kim; Ji Young Kang; Ki Tae Suk; Dong Joon Kim
Journal:  Scand J Infect Dis       Date:  2013-11-15

10.  Clinical features of infectious endophthalmitis in South Korea: a five-year multicenter study.

Authors:  Ki Yup Nam; Joo Eun Lee; Ji Eun Lee; Woo Jin Jeung; Jung Min Park; Jong Moon Park; In Young Chung; Yong Seop Han; Il Han Yun; Hyun Wong Kim; Ik Soo Byon; Boo Sup Oum; Hee Sung Yoon; Dong Park; Byeng Chul Yu; Eun-Kee Park; Hu-Jang Lee; Sang Joon Lee
Journal:  BMC Infect Dis       Date:  2015-04-09       Impact factor: 3.090

View more
  3 in total

1.  Case Series on Endogenous Klebsiella pneumoniae Endophthalmitis: More Than Meets the Eye.

Authors:  Pavitra Danapal; Mushawiahti Mustapha; Nur Syarafina Abdul Malek; Justin Yeak; Fazilawati A Qamarruddin
Journal:  Cureus       Date:  2021-06-25

2.  Metastatic endophthalmitis - Has the trend of causative organism changed in the modern antibiotic era - A Systematic Review.

Authors:  Meenakshi Wadhwani; Sanjay Kumar Mishra; Manika Manika; Shibal Bhartiya
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

3.  Acute Suppurative Thyroiditis with Thyroid Abscess by Klebsiella pneumoniae: An Unusual Presentation.

Authors:  Prashant Nasa; K G Mathew; Rakesh Sanker; Sandeep Chaudhary; Vikas Singhal
Journal:  Indian J Crit Care Med       Date:  2018-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.